scholarly journals Blinatumomab vs historic standard‐of‐care treatment for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukaemia

2020 ◽  
Vol 104 (4) ◽  
pp. 299-309 ◽  
Author(s):  
Nicola Gökbuget ◽  
Hervé Dombret ◽  
Sebastian Giebel ◽  
Monika Brüggemann ◽  
Michael Doubek ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukaemia ◽  
B Cell ◽  
Minimal Residual Disease ◽  
Lymphoblastic Leukaemia ◽  
Residual Disease ◽  
Standard Of Care ◽  
Cell Precursor ◽  
Care Treatment ◽  
Standard Of Care Treatment ◽  
Minimal Residual

scholarly journals Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease

2000 ◽  
Vol 110 (1) ◽  
pp. 139-146 ◽  
Author(s):  
Elisabeth R. Van Wering ◽  
Birgit E. M. Van der Linden-Schrever ◽  
Tomasz Szczepański ◽  
Marja J. Willemse ◽  
Ed A. Baars ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukaemia ◽  
B Cell ◽  
Minimal Residual Disease ◽  
Lymphoblastic Leukaemia ◽  
Residual Disease ◽  
B Cell Precursors ◽  
Minimal Residual
Sign in / Sign up

Export Citation Format

Share Document